Fuda Cancer Hospital is an early private entrant, specialized cancer hospital in China. Since its establishment 11 years ago, it has grown from a little-known private hospital to a well-known, specialized cancer hospital that has nearly 400 beds and attracts patients from more than 70 countries and regions. As China's healthcare care has long been dominated by public hospitals, Fuda Cancer Hospital was able to survive and grow by pursuing a differentiation-oriented strategy and a modern hospital management system. The hospital adheres to the strategy of "differentiated development" in the following aspects: Patient positioning - therapy of cancer in middle and advanced stage; Market positioning - Mainly overseas cancer patients in early stage Service; concept positioning - patient-centered, etc. To further expand operation, Fuda Cancer Hospital started to make preparations for IPO in 2011, planning to use the raised funds for hospital relocation and technical reform projects, scientific research and training center construction projects, and brand and market system restructuring projects. However, the hospital is faced with numerous setbacks in its endeavor to go public. From 2011 to 2013, the net revenue of the hospital has been declining, with a decrease of 47.80% in 2013. The cancer therapy, which the hospital is proud of, is challenged in the industry as it brings a negative impact on the IPO of the company. Moreover, since the national government has lifted policy restrictions on private capital in the medical market, many listed companies have invested in private hospitals, and Fuda Cancer Hospital will be confronted with fiercer competition. However, China's IPO market was frozen for nearly two years and Fuda experienced major roadblocks in its IPO journey.

【書誌情報】

ページ数：18ページ

サイズ：A4

商品番号：HBSP-TU0084

発行日：2015/6/23

登録日：2015/9/28